Cyprotex

Cyprotex is a contract research organization specialized in preclinical absorption, distribution, metabolism, and excretion (ADME).

Cyprotex specialises in preclinical ADME Tox, both in vitro (laboratory experiments) and in silico (computer modelling). Cyprotex was founded in 1999, and in 2002 it was listed on the London Stock Exchange’s AIM Market (symbol CRX, information for investors). Our headquarters are in Macclesfield, UK, near Manchester.